Surprisingly, although Rac activation has been implicated in anti-estrogen resistance in breast cancer cells, activation of Rac or Cdc42 by AND-34 is insufficient to induce anti-estrogen resistance as overexpression of any of the three NSP family members activates these GTPases [9]. This evidence concerns the gene AKT1 and breast carcinoma.